Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

About this update from Cannara Biotech, Inc.

[{"type":"text","content":"Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year\n\n\n\n MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) --\n \n Cannara Biotech Inc.\n \n (“\n \n Cannara\n \n ”, “the\n \n Company\n \n ”, “\n \n us\n \n ” or “\n \n we\n \n ”) (\n \n TSXV: LOVE\n \n ) (\n \n OTCQB: LOVFF\n \n ) (\n \n FRA: 8CB0\n \n ), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., is proud to announce that in recognition of its continued commitment to product excellence and innovation, Cannara was honored with two awards at the 6th Annual Grow Up Awards Gala held in Toronto on May 28, 2025. The Company’s Tribal brand was named Brand of the Year, and its Nugz Happle product was awarded the Accessory of the Year prize. The Grow Up Awards Gala is a nationally recognized event celebrating outstanding achievement in the Canadian cannabis industry. These accomplishments follow recent steps taken by the Company to reduce its cost of capital, including a partial repayment of its Olymbec convertible debenture and a reduction in the interest rate on its BMO credit facility.\n \n\n “We are tremendously honored to announce our recognition of Brand of the Year and Accessory of the Year at the 2025 Grow Up Awards. These awards highlight our strong and growing brand presence, our leading genetic strategy, and our focus on delivering premium-quality consumer experiences across our product portfolio,” said Zohar Krivorot, President & CEO of Cannara Biotech. “We’re proud to represent Quebec’s cannabis industry with Tribal, Canada’s leading mass market premium 3.5g cannabis brand.”\n \n\n “Being awarded Brand of the Year reflects our commitment to delivering premium cannabis at disruptive pricing while building a leading national brand. This recognition comes as we continue to strengthen our financial position through the partial repayment of our Olymbec convertible debenture and a reduced interest rate on our credit facility—demonstrating disciplined execution across both operations and capital management,” said Nicholas Sosiak, CFO of Cannara Biotech.\n \n\n The...

More updates from Cannara Biotech, Inc.